Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pinuccia Valagussa

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 2004
ABVD plus subtotal nodal versus involved-field radiotherapy in early-stage Hodgkin's disease: long-term resultsGianni Bonadonna, Valeria Bonfante, Simonetta Viviani, et al.
Annals of Surgical Oncology|January 18, 2007
Comment to "Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and intact primary tumor" by G V Babiera, R Rao, L Feng, F Meric-Bernstam, H M Kuerer, S E Singletary, K K Hunt, M I Ross, K M Gwyn, B W Feig, F C Ames, G N Horthobagyi. Ann Surg Oncol 2006;13:776-782Romano Demicheli, William J M Hrushesky, Michael W Retsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2004
Menopausal status dependence of early mortality reduction due to diagnosis of smaller breast cancers (T1 v T2-T3): relevance to screeningRomano Demicheli, Gianni Bonadonna, William J M Hrushesky, et al.
Breast Cancer Research and Treatment|September 27, 2005
Comment to Jatoi et al. reportRomano Demicheli, Gianni Bonadonna, Pinuccia Valagussa, et al.
BMJ (Clinical Research Ed.)|January 15, 2005
30 years' follow up of randomised studies of adjuvant CMF in operable breast cancer: cohort studyGianni Bonadonna, Angela Moliterni, Milvia Zambetti, et al.
International Journal of Cancer|April 25, 2003
Role of proliferation in HER2 status predicted response to doxorubicinManuela Campiglio, Giulia Somenzi, Clelia Olgiati, et al.
Clinical Breast Cancer|November 10, 2006
Capecitabine/Cyclophosphamide/Methotrexate for patients with metastatic breast cancer: a dose-finding, feasibility, and efficacy studyGabriella Mariani, Fausto Petrelli, Milvia Zambetti, et al.
Breast Cancer Research and Treatment|June 23, 2006
Comment to Anderson WF, Jatoi I, Devesa SS: distinct breast cancer incidence and prognostic patterns in the NCI'S SEER program: suggesting a possible link between etiology and outcome. Breast Cancer Res Treat 90:127-137, 2005Romano Demicheli, Gianni Bonadonna, Marco Greco, et al.
NPJ Precision Oncology|October 25, 2024
Development and validation of a gene expression-based Breast Cancer Purity ScoreMarco Barreca, Matteo Dugo, Barbara Galbardi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2008
Two distinct local relapse subtypes in invasive breast cancer: effect on their prognostic impactPatrizia Casalini, Maria Luisa Carcangiu, Raija Tammi, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 2004
ABVD plus subtotal nodal versus involved-field radiotherapy in early-stage Hodgkin's disease: long-term resultsGianni Bonadonna, Valeria Bonfante, Simonetta Viviani, et al.
Annals of Surgical Oncology|January 18, 2007
Comment to "Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and intact primary tumor" by G V Babiera, R Rao, L Feng, F Meric-Bernstam, H M Kuerer, S E Singletary, K K Hunt, M I Ross, K M Gwyn, B W Feig, F C Ames, G N Horthobagyi. Ann Surg Oncol 2006;13:776-782Romano Demicheli, William J M Hrushesky, Michael W Retsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2004
Menopausal status dependence of early mortality reduction due to diagnosis of smaller breast cancers (T1 v T2-T3): relevance to screeningRomano Demicheli, Gianni Bonadonna, William J M Hrushesky, et al.
Breast Cancer Research and Treatment|September 27, 2005
Comment to Jatoi et al. reportRomano Demicheli, Gianni Bonadonna, Pinuccia Valagussa, et al.
BMJ (Clinical Research Ed.)|January 15, 2005
30 years' follow up of randomised studies of adjuvant CMF in operable breast cancer: cohort studyGianni Bonadonna, Angela Moliterni, Milvia Zambetti, et al.
International Journal of Cancer|April 25, 2003
Role of proliferation in HER2 status predicted response to doxorubicinManuela Campiglio, Giulia Somenzi, Clelia Olgiati, et al.
Clinical Breast Cancer|November 10, 2006
Capecitabine/Cyclophosphamide/Methotrexate for patients with metastatic breast cancer: a dose-finding, feasibility, and efficacy studyGabriella Mariani, Fausto Petrelli, Milvia Zambetti, et al.
Breast Cancer Research and Treatment|June 23, 2006
Comment to Anderson WF, Jatoi I, Devesa SS: distinct breast cancer incidence and prognostic patterns in the NCI'S SEER program: suggesting a possible link between etiology and outcome. Breast Cancer Res Treat 90:127-137, 2005Romano Demicheli, Gianni Bonadonna, Marco Greco, et al.
NPJ Precision Oncology|October 25, 2024
Development and validation of a gene expression-based Breast Cancer Purity ScoreMarco Barreca, Matteo Dugo, Barbara Galbardi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2008
Two distinct local relapse subtypes in invasive breast cancer: effect on their prognostic impactPatrizia Casalini, Maria Luisa Carcangiu, Raija Tammi, et al.
Pageof 6